Express Healthcare
Home  »  News  »  BrainSightAI joins Dassault Systèmes’ 3DEXPERIENCE Lab to transform patient care and drug discovery for neuropsychiatric disorders

BrainSightAI joins Dassault Systèmes’ 3DEXPERIENCE Lab to transform patient care and drug discovery for neuropsychiatric disorders

0 237
Read Article

BrainSightAI is using BIOVIA applications to enable the implementation of enhanced machine-learning data pipelines and leveraging SIMULIA applications to create actionable 3D reports for doctors and patients, and simulate prognosis

Dassault Systèmes announced that the 3DEXPERIENCE Lab open innovation laboratory and accelerator programme is helping BrainSightAI, an Indian startup in neuroscience, in its efforts to revolutionise the diagnosis and prognosis of neuro-psychiatric disorders using artificial intelligence.

The BrainSightAI MRI solutions for functional and structural investigation give an unprecedented view into the patient, enabling early screening, diagnosis and modeling. It combines AI and neuroscience to enable greater precision in neurological and psychiatric investigation for accelerated patient outcomes.

As part of the 3DEXPERIENCE Lab at Pune, BrainSightAI is using BIOVIA and SIMULIA applications powered by the 3DEXPERIENCE platform to create a world-class next generation pipeline where data from clinical trials and real-world evidence from hospitals can feed into research and discovery of precision medicine.

Psychiatrists can leverage simulation technology to forecast challenges and outcomes for disorders such as schizophrenia, bipolar disorder and dementia. With SIMULIA applications, the team envisages the potential to develop actionable 3D visualisation reports with comprehensive insights for offline consultation. Through simulation of prognosis, doctors can easily develop a medication and therapy impact on the ailing patients.

“Early screening, early differential diagnosis and individualized modeling are the key imperatives for transforming the methodologies of mental health treatment,” said Laina Emmanuel, CEO, BrainSightAI. “With the help of Dassault Systemes’ 3DEXPERIENCE platform, our aim is to harness the power of Artificial Intelligence and Machine Learning for enabling a holistic view of patients that can lead to better outcomes and bring about a paradigm shift in how mental health is tackled as a public health issue.”

“As the Life Sciences industry moves towards more ‘personalised healthcare’, customised simulations allow for more precise analysis and predictions of human body dynamics. The 3DEXPERIENCE platform enables Life Sciences companies to deliver unmatched patient and physician experiences by connecting data, delivering life-like, multi-scale and multi-physics models, and enabling an end-to-end virtual environment for exploration, discovery, development, testing, and commercialisation,” said Frederic Vacher, Head of Innovation, Dassault Systèmes.

“The 3DEXPERIENCE Lab in Pune is mentoring three promising Indian startups in the domain of Life Sciences – Lucid Implants, Inali Foundation and BrainsightAI – that aim to deliver scalable solutions that will revolutionise patient care in the years ahead.”

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Want to know more about "Omic's" and it's relevance?
Register Now
close-image